Riverbend Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$583K	Buy	8,451 +471	+6%	+$32.5K	0.44%	65
2025 Q1	$554K	Buy	7,980 +3,325	+71%	+$231K	0.5%	62
2024 Q4	$401K	Buy	+4,655	New	+$401K	0.36%	78